Vasiliki Kalatzis

ORCID: 0000-0002-9626-8807
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Development and Disorders
  • CRISPR and Genetic Engineering
  • Biomedical Research and Pathophysiology
  • Neonatal Health and Biochemistry
  • Amino Acid Enzymes and Metabolism
  • Retinal Diseases and Treatments
  • Virus-based gene therapy research
  • Head and Neck Anomalies
  • Pluripotent Stem Cells Research
  • RNA regulation and disease
  • Photoreceptor and optogenetics research
  • Advanced biosensing and bioanalysis techniques
  • Hearing, Cochlea, Tinnitus, Genetics
  • Retinal and Optic Conditions
  • Mosquito-borne diseases and control
  • Retinal and Macular Surgery
  • Ocular Disorders and Treatments
  • Renal and related cancers
  • Retinal Imaging and Analysis
  • RNA and protein synthesis mechanisms
  • Connexins and lens biology
  • Glaucoma and retinal disorders
  • Ocular Oncology and Treatments
  • Lysosomal Storage Disorders Research
  • RNA modifications and cancer

Institute for Neurosciences of Montpellier
2016-2025

Inserm
2016-2025

Université de Montpellier
2014-2025

Hôpital Saint Eloi
2012-2024

Centre Hospitalier Universitaire de Montpellier
2024

Hôpital Gui de Chauliac
2018

Washington Center
2018

University of Washington
2018

Centre National de la Recherche Scientifique
1994-2014

Institut de Génétique Moléculaire de Montpellier
2003-2014

Mathieu Quinodoz Kim Rodenburg Zuzana Cvačková Karolina Kamińska Suzanne E. de Bruijn and 95 more Ana Belén Iglesias-Romero Erica G. M. Boonen Mukhtar Ullah Nick Zomer Marc Folcher Jacques Bijon Lara K. Holtes Stephen H. Tsang Zelia Corradi K. Bailey Freund Stefanida Shliaga Daan M. Panneman Rebekkah J. Hitti‐Malin Manir Ali Alaa AlTalbishi Sten Andréasson G. Ansari Gavin Arno Galuh Astuti Carmen Ayuso Radha Ayyagari Sandro Banfi Eyal Banin Mirella Telles Salgueiro Barboni Miriam Bauwens Tamar Ben‐Yosef David G. Birch Pooja Biswas Fiona Blanco‐Kelly Béatrice Bocquet Camiel J. F. Boon Kari Branham Alexis Ceecee Britten‐Jones Kinga M. Bujakowska Elizabeth L. Cadena Giacomo Calzetti Francesca Cancellieri Luca Cattaneo Peter Charbel Issa Naomi Chadderton Luísa Coutinho Santos Stephen P. Daiger Elfride De Baere Berta de la Cerda John N. De Roach Julie De Zaeytijd Ronny Derks Claire‐Marie Dhaenens Ľubica Ďuďáková Jacque L. Duncan G. Jane Farrar Nicolas Feltgen Lidia Fernández‐Caballero Juliana Maria Ferraz Sallum Simone Gana Alejandro Garanto Jessica C. Gardner Christian Gilissen Kensuke Goto Roser Gonzàlez‐Duarte Sam Griffiths‐Jones Tobias B. Haack Lonneke Haer‐Wigman Alison J. Hardcastle Takaaki Hayashi Elise Héon Alexander Hoischen Josephine Prener Holtan Carel B. Hoyng Manuel Benjamin B. Ibanez Chris F. Inglehearn Takeshi Iwata Kaylie Webb-Jones Vasiliki Kalatzis Smaragda Kamakari Marianthi Karali Ulrich Kellner Krisztina Knézy Caroline C. W. Klaver Robert K. Koenekoop Susanne Kohl Taro Kominami Laura Kuehlewein Tina M. Lamey Bart P. Leroy María Pilar Martín-Gutiérrez Nelson Martins L. Mauring Rina Leibu Siying Lin Petra Lišková Irma López Víctor Rodríguez Omar A. Mahroo Gae͏̈l Manes

The U4 small nuclear RNA (snRNA) forms a duplex with the U6 snRNA and, together U5 and ∼30 proteins, is part of U4/U6.U5 tri-snRNP complex, located at core major spliceosome. Recently, recurrent de novo variants in RNA, transcribed from RNU4-2 gene, least two other RNU genes were discovered to cause neurodevelopmental disorder. We detected inherited heterozygous (n.18_19insA n.56T>C) four out five RNU6 paralogues (n.55_56insG n.56_57insG) 135 individuals 62 families non-syndromic retinitis...

10.1101/2025.01.06.24317169 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2025-01-06

Cystinosis is an autosomal recessive disorder characterized by accumulation of intralysosomal cystine. The causative gene, CTNS, encodes cystinosin, a seven-transmembrane-domain protein, which we recently showed to be lysosomal cystine transporter. most severe and frequent form cystinosis, the infantile form, appears around 6 12 months, with proximal tubulopathy (de Toni-Debré-Fanconi syndrome) ocular damage. End-stage renal failure reached 10 years age. Accumulation in all tissues...

10.1128/mcb.22.21.7622-7632.2002 article EN Molecular and Cellular Biology 2002-10-07

Cystinosis is a lysosomal transport disorder characterized by an accumulation of intra-lysosomal cystine. Biochemical studies showed that the cystine transporter was distinct from plasma membrane transporters and it exclusively transported The gene underlying cystinosis,CTNS, encodes predicted seven-transmembrane domain protein called cystinosin, which highly glycosylated at N-terminal end carries GY-XX-Φ (where Φ hydrophobic residue) lysosomal-targeting motif in its carboxyl tail. We...

10.1074/jbc.m010562200 article EN cc-by Journal of Biological Chemistry 2001-04-01

Cystinosis is an inherited disorder characterized by defective lysosomal efflux of cystine. Three clinical forms (infantile, juvenile and ocular cystinosis) have been described according to the age onset severity symptoms. The causative gene, CTNS, encodes a seven transmembrane domain protein, cystinosin, which we recently identified as H+-driven cystine transporter using in vitro transport assay. In this study, explored relationship between activity intracellular localization cystinosin...

10.1093/hmg/ddh152 article EN Human Molecular Genetics 2004-05-10

Although it has been known for 50 years that adenoviruses (Ads) interact with erythrocytes ex vivo, the molecular and structural basis this interaction, which serendipitously exploited diagnostic tests, is unknown. In study, we characterized interaction between unrelated Ad serotypes, human 5 (HAd5) 37 (HAd37), canine 2 (CAV-2). While these serotypes agglutinate erythrocytes, they use different receptors, have tropisms and/or infect species. Using molecular, biochemical, transgenic...

10.1371/journal.ppat.1000277 article EN cc-by PLoS Pathogens 2009-01-02

Background. Cystinosis is caused by mutations in CTNS that encodes cystinosin, the lysosomal cystine transporter. The most severe and frequent form characterized a proximal tubulopathy appears around 6 to 12 months of age. In absence treatment, end-stage renal disease reached 10 years. Ctns−/− mice mixed 129Sv × C57BL/6 genetic background show elevated levels; however, or not observed.

10.1093/ndt/gfp553 article EN Nephrology Dialysis Transplantation 2009-10-21

Choroideremia (CHM) is an X-linked chorioretinal dystrophy that caused by mutations within a single gene, CHM Currently no effective treatment exists for these patients. Since over 30% of patients harbour nonsense in CHM, suppression therapy using translational readthrough inducing drugs may provide functional rescue REP1, thus attenuating progressive sight loss. Here, we employed two model systems to systematically test the efficacy and safety ataluren (PTC124) its novel analog PTC-414: (1)...

10.1093/hmg/ddw184 article EN Human Molecular Genetics 2016-06-21

Inherited retinal dystrophies (IRDs) comprise a large group of genetically and clinically heterogeneous diseases that lead to progressive vision loss, for which paucity disease-mimicking animal models renders preclinical studies difficult. We sought develop pertinent human cellular IRD models, beginning with choroideremia, caused by mutations in the CHM gene encoding Rab escort protein 1 (REP1). reprogrammed REP1-deficient fibroblasts from (-/y) patient into induced pluripotent stem cells...

10.1038/mtm.2014.11 article EN cc-by-nc-nd Molecular Therapy — Methods & Clinical Development 2014-01-01

Inherited retinal dystrophies (IRDs) are characterized by progressive photoreceptor degeneration and vision loss. Usher syndrome (USH) is a syndromic IRD retinitis pigmentosa (RP) hearing USH clinically genetically heterogeneous, the most prevalent causative gene USH2A. USH2A mutations also account for large number of isolated autosomal recessive RP (arRP) cases. This high prevalence due to two recurrent mutations, c.2276G>T c.2299delG. Due size cDNA, augmentation therapy inaccessible....

10.1016/j.omtm.2019.11.016 article EN cc-by-nc-nd Molecular Therapy — Methods & Clinical Development 2019-11-27

Journal Article A proposed new contiguous gene syndrome on 8q consists of Branchio-Oto-Renal (BOR) syndrome, Duane a dominant form hydrocephalus and trapeze aplasia; implications for the mapping BOR Get access Christophe Vincent, Vincent Unité de Génétique Moléculaire Humaine (CNRS URA 1445), Institut Pasteur25 rue du Dr Roux, 75724 Paris Cédex 15 Search other works by this author on: Oxford Academic PubMed Google Scholar Vasiliki Kalatzis, Kalatzis Sylvie Compain, Compain Jacqueline...

10.1093/hmg/3.10.1859 article EN Human Molecular Genetics 1994-01-01

Branchio-Oto-Renal (BOR) syndrome is an autosomal dominant, early developmental defect characterised by varying combinations of branchial (fistulas, sinuses, and cysts), outer, middle inner ear, renal anomalies. The gene underlying this syndrome, EYA1, homologous to the Drosophila eyes absent which encodes a transcriptional co-activator required for eye specification. We report here temporal spatial pattern expression murine homologue, Eya1, throughout ear kidney development in relation...

10.1002/(sici)1097-0177(199812)213:4<486::aid-aja13>3.0.co;2-l article EN Developmental Dynamics 1998-12-01

Choroideremia (CHM) is a rare X-linked disease leading to progressive retinal degeneration resulting in blindness. The disorder caused by mutations the CHM gene encoding REP-1 protein, an essential component of Rab geranylgeranyltransferase (GGTase) complex. In present study, we evaluated multi-technique analysis algorithm describe mutational spectrum identified large cohort cases and further correlate variants with phenotypic characteristics biochemical defects choroideremia patients....

10.1371/journal.pone.0151943 article EN cc-by PLoS ONE 2016-04-12

Zika virus (ZIKV) has recently re-emerged as a pathogenic agent with epidemic capacities was well illustrated in South America. Because of the extent this health crisis, number more serious symptoms have become associated ZIKV infection than what initially described. In particular, neuronal and ocular disorders been characterized, both infants adults. Notably, macula retina can be strongly affected by ZIKV, possibly direct effect virus. This is supported detection replicative infectious...

10.1016/j.ebiom.2018.12.010 article EN cc-by-nc-nd EBioMedicine 2018-12-20

Usutu virus (USUV), an African mosquito-borne flavivirus closely related to West Nile virus, was first isolated in South Africa 1959. USUV emerged Europe two decades ago, causing notably massive mortality Eurasian blackbirds. is attracting increasing attention due its potential for emergence and rapid spread recent years. Although mainly asymptomatic or responsible mild clinical signs, recently described as being associated with neurological disorders humans such encephalitis...

10.1371/journal.pntd.0008223 article EN cc-by PLoS neglected tropical diseases 2020-04-23

Retinitis pigmentosa (RP) is an inherited retinal dystrophy that causes progressive vision loss. The G56R mutation in NR2E3 the second most common causing autosomal dominant (ad) RP, a transcription factor essential for photoreceptor development and maintenance. variant exclusively responsible all cases of NR2E3-associated adRP. Currently, there no treatment NR2E3-related or, other, adRP, but genome editing holds promise. A pertinent approach would be to specifically knockout mutant allele,...

10.3390/ijms22052607 article EN International Journal of Molecular Sciences 2021-03-05

Human-induced pluripotent stem cell-derived retinal organoids are a valuable tool for disease modelling and therapeutic development. Many efforts have been made over the last decade to optimise protocols generation of that correctly mimic human retina. Most use common media supplements; however, protocol-dependent variability impacts data interpretation. To date, lack systematic comparison given protocol with or without supplements makes it difficult determine how they influence...

10.1186/s13287-022-03146-x article EN cc-by Stem Cell Research & Therapy 2022-09-16

There is an emblematic clinical and genetic heterogeneity associated with inherited retinal diseases (IRDs). The most common form retinitis pigmentosa (RP), a rod-cone dystrophy caused by pathogenic variants in over 80 different genes. Further complexifying diagnosis, individual RP genes can also alter the phenotype. USH2A prevalent gene for autosomal-recessive one of challenging because its large size and, hence, number variants. Moreover, give rise to non-syndromic syndromic RP, known as...

10.1016/j.xhgg.2023.100229 article EN cc-by-nc-nd Human Genetics and Genomics Advances 2023-08-07

Retinitis pigmentosa (RP) is the most common inherited retinal disease (IRD) and characterized by photoreceptor degeneration progressive vision loss. We report 4 patients presenting with RP from 3 unrelated families variants in TBC1D32, which to date has never been associated an IRD. To validate TBC1D32 as a putative causative gene, we combined Xenopus vivo approaches human induced pluripotent stem cell-derived (iPSC-derived) models. Our data showed that was expressed during development it...

10.1172/jci.insight.169426 article EN cc-by JCI Insight 2023-09-28
Coming Soon ...